Price
Target price
€0.32
€0.32
-
-
-
€1.60
25.04.24 / Stuttgart Stock Exchange
WKN: A3DHEU / Symbol: NVIV / Name: InVivo Therapeutics Holdings / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
InVivo Therapeutics Holdings Stock
The sentiment is rather negative at the moment with 18 Sell predictions and 1 Buy predictions.
On the other hand, the target price of 1 € is above the current price of 0.32 € for InVivo Therapeutics Holdings, so the potential is actually 214.47%.
So far the community has only identified positive things for InVivo Therapeutics Holdings stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of InVivo Therapeutics Holdings in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InVivo Therapeutics Holdings vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | -0.625% | 47.564% | -71.403% | -53.779% | -99.933% | -99.967% |
| Star Equity Holdings Inc. | -1.850% | 1.274% | -3.636% | 15.217% | -15.426% | -67.418% | -87.918% |
| Atossa Genetics Inc | 5.770% | 11.232% | -12.996% | 161.892% | 51.541% | -11.867% | -61.912% |
| Medmira Inc. | - | 8.235% | -6.122% | -19.298% | -29.231% | - | - |
Comments
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat